Biopharmaceutical benchmarks 2018

Nat Biotechnol. 2018 Dec 6;36(12):1136-1145. doi: 10.1038/nbt.4305.

Author

Gary Walsh¹

Affiliation

¹ Industrial Biochemistry Program, Department of Chemical Sciences and Bernal Institute, University of Limerick, Ireland.

PMID: 30520869
DOI: 10.1038/nbt.4305

No abstract available

MeSH terms

Animals
Antibodies, Monoclonal
Benchmarking
Biological Products
Biosimilar Pharmaceuticals
Biotechnology / trends
Drug Approval*
Drug Industry* / trends
European Union
Humans
Nucleic Acids
Recombinant Proteins
United States
United States Food and Drug Administration

Substances

Antibodies, Monoclonal
Biological Products
Biosimilar Pharmaceuticals
Nucleic Acids
Recombinant Proteins